H.R. 10370, the Ailani Myers Accelerating Innovation in Medicine to Cure Kids with Cancer Act, directs the federal government to better coordinate efforts using artificial intelligence and advanced technologies to improve diagnosis, treatment, prevention, and cures for childhood cancer. The President must designate a Coordinator of AI Innovation to align activities across multiple federal agencies including the National Institutes of Health, Food and Drug Administration, Department of Defense, and others. The National Cancer Institute will carry out a Childhood Cancer Data Initiative to collect and share data on pediatric cancer patients while developing AI tools and standards for data interoperability, with a specific focus on improving clinical trials and treatment outcomes. The bill requires reports to Congress within 180 days and annually through 2031 on implementation progress, data sharing outcomes, and barriers to advancement. It authorizes $100 million annually for fiscal years 2027 through 2031 specifically for the Childhood Cancer Data Initiative, plus additional unspecified funding for other program activities, with all work conducted in compliance with patient privacy laws.